267.80SEK-3.25%Mkt Cap: 8.44B SEKP/E: 113.96Last update: 2026-06-01
Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap8.44B SEK
Enterprise Value8.53B SEK
Revenue (TTM)834.53M SEK
Gross Profit599.49M SEK
Net Income (TTM)25.16M SEK
Revenue/Share26.49 SEK
Last Price267.80 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees199
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0004840718
Valuation
P/E (Trailing)113.96
P/E (Forward)46.84
PEG—
EV/EBITDA62.19
EV/Revenue10.23
P/S10.45
P/B4.13
EPS (TTM)2.24
EPS (Forward)5.91
52W Range
160.0066% of range322.40
52W High322.40 SEK
52W Low160.00 SEK
Profitability
Gross Margin73.81%
Oper. Margin13.26%
EBITDA Margin16.44%
Profit Margin3.10%
ROE1.19%
ROA1.06%
Growth
Revenue Growth10.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF101.07M SEK
CapEx (TTM)252.91M SEK
FCF Margin-10.36%
FCF Yield-1.03%
Net Debt-185.46M SEK
Net Debt/EBITDA-1.35
Balance Sheet
Debt/Equity0.06
Current Ratio4.52
Quick Ratio3.10
Book Value/Sh67.09 SEK
Cash/Share9.782 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)350.00 SEK
Target Range320.00 SEK – 385.00 SEK
# Analysts5
Ownership
Shares Out.31.50M
Float25.13M
Insiders7.85%
Institutions62.44%
Technical
SMA 50267.61 (+0.1%)
SMA 200204.02 (+31.3%)
Beta1.42
S&P 52W Chg27.70%
Avg Vol (30d)77.96K
Avg Vol (10d)60.63K
Technical Indicators
RSI (14)47.6
MACD5.7943
MACD Signal8.0705
MACD Hist.-2.2762
BB Upper299.75 SEK
BB Middle284.63 SEK
BB Lower269.51 SEK
BB Width10.63%
ATR (14)11.17 SEK
Vol Ratio (20d)3.83x